100% Quality Guarantee
PhD-Level Technical Support
Human Cell Cycle ELISA Kits 1 Human MCTS1 / Malignant T cell amplified sequence 1 ELISA Kit
Key Features

Human MCTS1/Malignant T cell amplified sequence 1 ELISA Kit (HUFI01426)

SKU HUFI01426
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 46.875 pg/mL
Range 78.125-5000 pg/mL
€649

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human MCTS1/Malignant T cell amplified sequence 1 ELISA Kit

The Human MCTS1 (Malignant T-Cell Amplified Sequence 1) ELISA Kit is specifically designed for the precise measurement of MCTS1 levels in human samples including serum, plasma, and cell culture supernatants. This state-of-the-art kit offers exceptional sensitivity and specificity, guaranteeing accurate and dependable results for various research applications. MCTS1 is a vital protein implicated in T-cell lymphoma and leukemia, playing a crucial role in cancer development and progression.

Its dysregulation has been associated with the pathogenesis of various hematological malignancies, making it a key biomarker for studying these diseases and exploring potential therapeutic interventions. Overall, the Human MCTS1 ELISA Kit provides researchers with a powerful tool to investigate the role of MCTS1 in cancer biology and potentially identify novel strategies for diagnosing and treating T-cell malignancies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose